The study of antitumor efficacy of bevacizumab antiangiogenic therapy using a mathematical model
From MaRDI portal
Publication:890244
DOI10.1515/RNAM-2015-0026zbMath1325.92046OpenAlexW2565884202MaRDI QIDQ890244
Andrey V. Kolobov, Maxim B. Kuznetsov, Vladimir V. Gubernov
Publication date: 10 November 2015
Published in: Russian Journal of Numerical Analysis and Mathematical Modelling (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1515/rnam-2015-0026
Related Items (4)
Optimization of Combined Antitumor Chemotherapy with Bevacizumab by Means of Mathematical Modeling ⋮ Analysis of anticancer efficiency of combined fractionated radiotherapy and antiangiogenic therapy via mathematical modelling ⋮ Mathematical modelling of chemotherapy combined with bevacizumab ⋮ Mathematical modelling for spatial optimization of irradiation during proton radiotherapy with nanosensitizers
This page was built for publication: The study of antitumor efficacy of bevacizumab antiangiogenic therapy using a mathematical model
